130 related articles for article (PubMed ID: 1330982)
21. Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors.
Orlova A; Tran T; Widström C; Engfeldt T; Eriksson Karlström A; Tolmachev V
Int J Mol Med; 2007 Sep; 20(3):397-404. PubMed ID: 17671747
[TBL] [Abstract][Full Text] [Related]
22. A comparative distribution study of 111In-labeled DTPA and TTHA monoclonal antibody conjugates in a choriocarcinoma xenograft model.
Buckley RG; Barnett P; Searle F; Pedley R; Boden JA
Eur J Nucl Med; 1986; 12(8):394-6. PubMed ID: 3098566
[TBL] [Abstract][Full Text] [Related]
23. Labelling of monoclonal antibodies 10B, 8C, and M2A with indium-111.
Reilly R; Sheldon K; Marks A; Houle S
Int J Rad Appl Instrum A; 1989; 40(4):279-83. PubMed ID: 2543652
[TBL] [Abstract][Full Text] [Related]
24. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N
Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723
[TBL] [Abstract][Full Text] [Related]
25. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
26. [Potential application of DTPA for improving the image quality in radioimmunoscintigraphy with 111In labeled monoclonal antibodies].
Ochi K; Fujii T; Kimura Y; Akamune A; Hamamoto K
Kaku Igaku; 1992 Jan; 29(1):69-75. PubMed ID: 1578822
[TBL] [Abstract][Full Text] [Related]
27. Use of isothiocyanatobenzyl-DTPA derivatized monoclonal antimyosin fab for enhanced in vivo target localization.
Khaw BA; Gansow O; Brechbiel MW; O'Donnell SM; Nossiff N
J Nucl Med; 1990 Feb; 31(2):211-7. PubMed ID: 2313361
[TBL] [Abstract][Full Text] [Related]
28. N,N'-bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1,2 -ethylenediamine-N,N'-diacetic acid: a new bifunctional chelate for radiolabeling antibodies.
Mathias CJ; Sun YZ; Welch MJ; Connett JM; Philpott GW; Martell AE
Bioconjug Chem; 1990; 1(3):204-11. PubMed ID: 2129013
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
30. Optimization of the DTPA mixed-anhydride reaction with antibodies at low concentration.
Paik CH; Murphy PR; Eckelman WC; Volkert WA; Reba RC
J Nucl Med; 1983 Oct; 24(10):932-6. PubMed ID: 6619963
[TBL] [Abstract][Full Text] [Related]
31. Serum stability of 67Cu chelates: comparison with 111In and 57Co.
Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK
Int J Rad Appl Instrum B; 1986; 13(4):363-8. PubMed ID: 3539884
[TBL] [Abstract][Full Text] [Related]
32. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
[TBL] [Abstract][Full Text] [Related]
33. Improved tumor localization of 111In labeled monoclonal antibody with chelator administration to host nude mice.
Lockshin A; Stehlin JS
Eur J Nucl Med; 1987; 12(11):573-5. PubMed ID: 3106043
[TBL] [Abstract][Full Text] [Related]
34. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
[TBL] [Abstract][Full Text] [Related]
35. Relative reactivity of DTPA, immunoreactive antibody-DTPA conjugates, and nonimmunoreactive antibody-DTPA conjugates toward indium-111.
Paik CH; Hong JJ; Ebbert MA; Heald SC; Reba RC; Eckelman WC
J Nucl Med; 1985 May; 26(5):482-7. PubMed ID: 3989604
[TBL] [Abstract][Full Text] [Related]
36. Stability of a metabolizable ester bond in radioimmunoconjugates.
Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
[TBL] [Abstract][Full Text] [Related]
37. Stability, targeting, and biodistribution of scandium-46- and gallium-67-labeled monoclonal antibody in erythroleukemic mice.
Anderson WT; Strand M
Cancer Res; 1985 May; 45(5):2154-8. PubMed ID: 3857116
[TBL] [Abstract][Full Text] [Related]
38. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.
Carrasquillo JA; White JD; Paik CH; Raubitschek A; Le N; Rotman M; Brechbiel MW; Gansow OA; Top LE; Perentesis P; Reynolds JC; Nelson DL; Waldmann TA
J Nucl Med; 1999 Feb; 40(2):268-76. PubMed ID: 10025834
[TBL] [Abstract][Full Text] [Related]
39. A method for direct quantification of the amount of DTPA in 111In monoclonal antibody preparations.
Wang TS; NG AK; Alsedairy S; Fawwaz RA; Hardy MA; Alderson PO
Int J Rad Appl Instrum A; 1987; 38(4):315-9. PubMed ID: 3040633
[TBL] [Abstract][Full Text] [Related]
40. Use of new heterobifunctional reagent for radiometallic labeling of antibodies.
Wang TS; Ng AK; Alsedairy S; Fawwaz RA; Hardy MA; Alderson PO
NCI Monogr; 1987; (3):145-8. PubMed ID: 3821912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
